EFFECTS OF ILOPROST ON ENDOTHELIAL CELL DYSFUNCTION IN PULMONARY ARTERIAL HYPERTENSION ASSOCIATED TO SYSTEMIC SCLERODERMA

被引：0
|
作者：
Yatsyshyn, R. [1 ]
Neyko, Y. E. [1 ]
Yatsyshyn, N. [1 ]
机构：
[1] Ivano Frankivsk Natl Med Univ, Ivano Frankivsk, Ukraine
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷
关键词：
D O I：
10.1097/01.hjh.0000378579.22376.c8
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E126 / E126
页数：1
相关论文
共 50 条
  • [31] Efficacy of Imatinib Mesylate on Scleroderma Associated Pulmonary Arterial Hypertension
    Maki, H.
    Hatano, M.
    Yao, A.
    Imamura, T.
    Asada, K.
    Inaba, T.
    Shiga, T.
    Kinugawa, K.
    Nagai, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S212 - S213
  • [32] Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension
    Johnson, Sindhu R.
    Swinton, John R.
    Granton, John T.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (08) : 1584 - 1590
  • [33] Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension
    Good, Robert B.
    Gilbane, Adrian J.
    Trinder, Sarah L.
    Denton, Christopher P.
    Coghlan, Gerry
    Abraham, David J.
    Holmes, Alan M.
    AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (07): : 1850 - 1858
  • [34] Inhaled iloprost for therapy in pulmonary arterial hypertension
    Ewert, Ralf
    Glaeser, Sven
    Bollmann, Tom
    Schaeper, Christoph
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (02) : 145 - 152
  • [35] Pulmonary Vascular Platform Models the Effects of Flow and Pressure on Endothelial Dysfunction in BMPR2 Associated Pulmonary Arterial Hypertension
    D'Amico, Reid W.
    Faley, Shannon
    Shim, Ha-na
    Prosser, Joanna R.
    Agrawal, Vineet
    Bellan, Leon M.
    West, James D.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (09)
  • [36] CRYOFIBRINOGEN-ASSOCIATED SYSTEMIC SCLEROSIS: POSSIBLE CORRELATIONS WITH SCLERODERMA DIGITAL ULCERS AND PULMONARY ARTERIAL HYPERTENSION
    Amati, G.
    Spinella, A.
    Sandri, G.
    Natali, P.
    Debbia, D.
    Mascia, M. T.
    Salvarani, C.
    Giuggioli, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 745 - 746
  • [37] Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension
    Hoeper, MM
    Spiekerkoetter, E
    Westerkamp, V
    Gatzke, R
    Fabel, H
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (02) : 339 - 343
  • [38] Bosentan synergizes with iloprost in treating pulmonary hypertension in scleroderma patients
    Sessarego, Marta
    Rizzi, Marta
    Ghio, Massimo
    Indiveri, Francesco
    CLINICAL IMMUNOLOGY, 2007, 123 : S85 - S85
  • [39] Shear stress quantification and regulation of endothelial cell dysfunction in models of pulmonary arterial hypertension
    Tang, Beverly T.
    Fonte, Tim A.
    Feinstein, Jeffrey A.
    Taylor, Charles A.
    Tsao, Philip S.
    CIRCULATION, 2006, 114 (18) : 81 - 81
  • [40] Determinants of pulmonary arterial hypertension in scleroderma
    Plastiras, Sotiris C.
    Karadimitrakis, Stylianos P.
    Kampolis, Christos
    Moutsopoulos, Haralampos M.
    Tzelepis, George E.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2007, 36 (06) : 392 - 396
12345